PubMed · 10437709
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
G E Larijani. 1999-06-01. Evaluating neuromuscular blocking agents. Introduction.. https://doi.org/10.1093/ajhp%2F56.s3
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
A series of 3,3-disubstituted quinoxalinones was prepared and evaluated as HIV-1 reverse transcriptase inhibitors. The N-allyl (6b and 6f), N-cyclopropylmethyl (6a, 6g, 6h, and 6k) and N-carboalkoxy (6m-6y) substituted compounds displayed activity comparable or better than Efavirenz and GW420867X.
A series of substituents was installed at the 3 position of farnesyl diphosphate through a copper-cyanide mediated coupling of a vinyl triflate with various Grignard reagents. These novel FPP mimetics were then evaluated as inhibitors of or substrates for mammalian protein farnesyl transferase. The IC50 values for these compounds range from 18 to 10,100 nm, with the 3-isopropenyl analogue being one of the most potent FPP-mimetic mFTase inhibitors yet synthesized.
Explore the source record for details and available documents.